Race-day Medication

Commentary
How phasing out U.S. race-day medication may affect the European sales market
Geir Stabell | Oct 16, 2019 |
Racing
Building an international syndicate: The man behind Team Valor
Karen M Johnson | Mar 4, 2015 |

Racing
Gosden: How the Great American Thoroughbred could become increasingly irrelevant
Julian Muscat | Jan 27, 2015 |
Commentary
Swift investigation into Australian cobalt positives highlights U.S. regulatory inefficiencies
Charles Hayward | Jan 22, 2015 |
Racing
What happens when everyone agrees to put the horse first?
Dr. Jennifer Durenberger | Oct 6, 2014 |
Racing
The furosemide debate: Why it's not such a big issue in Europe
Lissa Oliver | Sep 17, 2014 |
Racing
Jones: "Either we eliminate the problem, or the problem is going to eliminate us"
Glenye Cain Oakford | Aug 27, 2014 |